# GCLC

## Overview
The GCLC gene encodes the glutamate-cysteine ligase catalytic subunit, a critical enzyme in the biosynthesis of glutathione (GSH), a major antioxidant in human cells. This enzyme is categorized as a ligase and is responsible for catalyzing the formation of gamma-glutamylcysteine from glutamate and cysteine, a rate-limiting step in GSH production (Franklin2009Structure). The protein functions in the cytoplasm and is essential for maintaining cellular redox balance, detoxification, and overall cellular homeostasis (Efanova2023Polymorphismsa). GCLC's activity is modulated by interactions with other proteins and post-translational modifications, which are crucial for its role in responding to oxidative stress and protecting cells from damage (Zhao2024GCLC; Franklin2009Structure). Variations in the GCLC gene have been linked to several clinical conditions, highlighting its importance in human health (Dalton2004Genetically).

## Function
The GCLC gene encodes the catalytic subunit of glutamate-cysteine ligase, which is essential for the synthesis of glutathione (GSH), a critical antioxidant in human cells. GCLC catalyzes the formation of gamma-glutamylcysteine from glutamate and cysteine, a rate-limiting step in GSH biosynthesis, requiring ATP and Mg++ as cofactors (Franklin2009Structure). This enzyme is active in the cytoplasm and plays a vital role in maintaining cellular redox balance, detoxification, and cellular homeostasis (Efanova2023Polymorphismsa).

GSH, synthesized through the action of GCLC, is involved in various cellular processes, including protein synthesis, DNA synthesis and repair, cell proliferation, and redox signaling (Franklin2009Structure). It also plays a significant role in protecting cells from oxidative stress by neutralizing free radicals and detoxifying harmful substances (Efanova2023Polymorphismsa). In the skin, GSH is crucial for maintaining skin integrity and promoting effective wound healing (Efanova2023Polymorphismsa).

The activity of GCLC is regulated by post-translational modifications, such as phosphorylation, which can modulate its enzymatic activity and thus influence GSH levels in response to oxidative stress (Franklin2009Structure). This regulation is essential for maintaining cellular health and responding to environmental challenges.

## Clinical Significance
Mutations and polymorphisms in the GCLC gene, which encodes the catalytic subunit of glutamate-cysteine ligase, have significant clinical implications. The GCLC gene is crucial for glutathione (GSH) synthesis, and its disruption can lead to various health issues. Mutations in the GCLC gene can result in GCL deficiency, characterized by low GCL activity and reduced GSH levels in erythrocytes. This deficiency is associated with hemolytic anemia, transient jaundice, and, in some cases, central nervous system disorders (Dalton2004Genetically).

Specific single nucleotide polymorphisms (SNPs) in the GCLC gene, such as À129C Y T, have been identified as risk factors for myocardial infarction, independent of traditional coronary heart disease risk factors. This mutation leads to a GCLC promoter with approximately 50% lower basal activity, affecting endothelial cell function and coronary artery vasomotor function (Dalton2004Genetically).

In cystic fibrosis, polymorphisms in the GCLC gene, including -129C > T and -3506A > G, have been linked to variations in disease severity. These polymorphisms affect GSH production and are associated with different phenotypes of cystic fibrosis severity, particularly in relation to pulmonary disease (Marson2014Polymorphisms).

## Interactions
The glutamate-cysteine ligase catalytic subunit (GCLC) is involved in several protein interactions that are crucial for its function in glutathione synthesis. GCLC forms a heterodimer with the glutamate-cysteine ligase modifier subunit (GCLM), which modulates its enzymatic activity by lowering the Km for glutamate and increasing the Ki for glutathione (Franklin2002Caspase3Dependent). This interaction is essential for the enzyme's activity and response to oxidative stress (Soltaninassab2000Multifaceted).

GCLC also interacts with SIRT2, a sirtuin family protein, which desuccinylates GCLC, enhancing its activity under oxidative stress conditions. This interaction is confirmed through co-immunoprecipitation and GST pull-down assays, indicating a direct interaction that is crucial for regulating GCLC activity and protecting cells from ferroptosis (Zhao2024GCLC).

Additionally, GCLC is a target for caspase-3-mediated cleavage during apoptosis, which may affect its interaction with GCLM and influence glutathione biosynthesis (Franklin2002Caspase3Dependent). Despite cleavage, GCLC retains the ability to associate with GCLM, suggesting that the interaction remains functionally significant (Franklin2009Structure). These interactions highlight the complex regulatory mechanisms involving GCLC in cellular antioxidant defense.


## References


[1. (Dalton2004Genetically) Timothy P. Dalton, Ying Chen, Scott N. Schneider, Daniel W. Nebert, and Howard G. Shertzer. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radical Biology and Medicine, 37(10):1511–1526, November 2004. URL: http://dx.doi.org/10.1016/j.freeradbiomed.2004.06.040, doi:10.1016/j.freeradbiomed.2004.06.040. This article has 225 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.freeradbiomed.2004.06.040)

[2. (Soltaninassab2000Multifaceted) Syrus R. Soltaninassab, Konjeti R. Sekhar, Michael J. Meredith, and Michael L. Freeman. Multi-faceted regulation of ?-glutamylcysteine synthetase. Journal of Cellular Physiology, 182(2):163–170, February 2000. URL: http://dx.doi.org/10.1002/(sici)1097-4652(200002)182:2<163::aid-jcp4>3.0.co;2-1, doi:10.1002/(sici)1097-4652(200002)182:2<163::aid-jcp4>3.0.co;2-1. This article has 100 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(sici)1097-4652(200002)182:2)

[3. (Efanova2023Polymorphismsa) Ekaterina Efanova, Olga Bushueva, Roman Saranyuk, Anna Surovtseva, Mikhail Churnosov, Maria Solodilova, and Alexey Polonikov. Polymorphisms of the gclc gene are novel genetic markers for susceptibility to psoriasis associated with alcohol abuse and cigarette smoking. Life, 13(6):1316, June 2023. URL: http://dx.doi.org/10.3390/life13061316, doi:10.3390/life13061316. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.3390/life13061316)

[4. (Franklin2002Caspase3Dependent) Christopher C. Franklin, Cecile M. Krejsa, Robert H. Pierce, Collin C. White, Nelson Fausto, and Terrance J. Kavanagh. Caspase-3-dependent cleavage of the glutamate-l-cysteine ligase catalytic subunit during apoptotic cell death. The American Journal of Pathology, 160(5):1887–1894, May 2002. URL: http://dx.doi.org/10.1016/s0002-9440(10)61135-2, doi:10.1016/s0002-9440(10)61135-2. This article has 65 citations.](https://doi.org/10.1016/s0002-9440(10)61135-2)

[5. (Franklin2009Structure) Christopher C. Franklin, Donald S. Backos, Isaac Mohar, Collin C. White, Henry J. Forman, and Terrance J. Kavanagh. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Molecular Aspects of Medicine, 30(1–2):86–98, February 2009. URL: http://dx.doi.org/10.1016/j.mam.2008.08.009, doi:10.1016/j.mam.2008.08.009. This article has 318 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2008.08.009)

6. (Zhao2024GCLC) GCLC desuccinylation regulated by oxidative stress protects human cancer cells from ferroptosis. This article has 0 citations.

[7. (Marson2014Polymorphisms) Fernando Augusto de Fernando August Marson, Carmen Silvia Bertuzzo, Antonio Fernando Ribeiro, and Jose Dirceu Ribeiro. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. BMC Medical Genetics, March 2014. URL: http://dx.doi.org/10.1186/1471-2350-15-27, doi:10.1186/1471-2350-15-27. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2350-15-27)